Pharma Journalist -

Amunix Pharmaceuticals, Inc. announced the successful completion of an oversubscribed $73 million Series A financing. Boston-based Omega Funds led the financing, with participation from…
Read More...

Arcturus Therapeutics and Duke-NUS Medical School (Duke-NUS) announced their partnership to develop a Coronavirus (COVID-19) vaccine for Singapore. The development of a COVID-19 vaccine…
Read More...

Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), and Servier, an international…
Read More...

MIMETAS announces the first product release of her Assay Ready product line: OrganoPlate Caco-2. The product consists of 38 intestinal tubules that are grown under flow conditions…
Read More...

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of assay development and advanced laboratory testing is pleased to announce the signing of a…
Read More...

Inovio Pharmaceuticals, Inc. announced an accelerated timeline for developing its DNA vaccine INO-4800 to address COVID-19, the respiratory infection the World Health Organization (WHO)…
Read More...

Heat Biologics, Inc. announced that the Company has formally launched a program within its wholly-owned subsidiary, Zolovax, Inc., to develop a vaccine using its immune activating gp96…
Read More...

SMi Group interviews SKAN AG’s Richard Denk for the upcoming Highly Potent Active Pharmaceutical Ingredients conference in May. The 4th annual Highly Potent Active Pharmaceutical…
Read More...

ACADIA Pharmaceuticals Inc. and Neuren Pharmaceuticals Limited announced that the U.S. Food and Drug Administration (FDA) granted Rare Pediatric Disease (RPD) designation to trofinetide…
Read More...

MilliporeSigma launched its LANEXO Lab Inventory, Safety and Compliance Management System, a new digital laboratory informatics solution designed to drastically reduce time in labs and…
Read More...